Alzheimer’s drug development tends to focus on protein aggregates in the brain. Perhaps that’s why they’ve all failed.
Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.
New findings suggest that a person’s own immune system helps nudge him or her down the path toward Parkinson’s, and that restraining the immune system with drugs potentially could prevent the neurological disorder.
In a new multicenter clinical trial, a personalised vaccine improved the survival rates of some people with the deadly brain cancer glioblastoma.
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according to a landmark study.
Bill Hinshaw has left his position as Executive Vice President of US Oncology at Novartis, to assume the role of CEO at Axcella Health.
Researchers who’ve created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
A team of researchers has unveiled a novel statistical algorithm, capable of identifying potential disease genes in a more accurate and cost-effective way.
Activating an olfactory receptor in prostate cancer cells causes them to morph into a more aggressive form.
Michigan based researchers identify long noncoding RNA transcript as important molecule in prostate cancer progression. If you’re new to noncoding RNAs and cancer, this might be useful to read first!
It’s been a recurring refrain: Africa still lags woefully behind the rest of the world in generating new scientific knowledge. But there are several projects that offer hope amid all the bad news.
Chemists have devised a way to rapidly synthesize and screen millions of novel proteins that could be used as drugs against Ebola and other viruses.